176 related articles for article (PubMed ID: 38117242)
1. Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments.
Zugbi S; Aschero R; Ganiewich D; Cancela MB; Winter U; Ottaviani D; Sampor C; Dinardi M; Torbidoni AV; Mena M; Balaguer-Lluna L; Lamas G; Sgroi M; Lagomarsino E; Lubieniecki F; Fandiño A; Radvanyi F; Abramson DH; Podhajcer O; Llera AS; Cafferata EG; Chantada G; Carcaboso AM; Schaiquevich P
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):27. PubMed ID: 38117242
[TBL] [Abstract][Full Text] [Related]
2. Genomic and Transcriptomic Tumor Heterogeneity in Bilateral Retinoblastoma.
Winter U; Ganiewich D; Ottaviani D; Zugbi S; Aschero R; Sendoya JM; Cafferata EG; Mena M; Sgroi M; Sampor C; Lubieniecki F; Fandiño A; Abba MC; Doz F; Podhjacer O; Carcaboso AM; Letouzé E; Radvanyi F; Chantada GL; Llera AS; Schaiquevich P
JAMA Ophthalmol; 2020 May; 138(5):569-574. PubMed ID: 32191268
[TBL] [Abstract][Full Text] [Related]
3. Association of Cone-Rod Homeobox Transcription Factor Messenger RNA With Pediatric Metastatic Retinoblastoma.
Torbidoni AV; Laurent VE; Sampor C; Ottaviani D; Vazquez V; Gabri MR; Rossi J; de Dávila MT; Alonso C; Alonso DF; Chantada GL
JAMA Ophthalmol; 2015 Jul; 133(7):805-12. PubMed ID: 25928893
[TBL] [Abstract][Full Text] [Related]
4. Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination.
Pascual-Pasto G; Olaciregui NG; Vila-Ubach M; Paco S; Monterrubio C; Rodriguez E; Winter U; Batalla-Vilacis M; Catala J; Salvador H; Parareda A; Schaiquevich P; Suñol M; Mora J; Lavarino C; de Torres C; Chantada GL; Carcaboso AM
Cancer Lett; 2016 Sep; 380(1):10-9. PubMed ID: 27319373
[TBL] [Abstract][Full Text] [Related]
5. Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma.
Torbidoni AV; Sampor C; Laurent VE; Aschero R; Iyer S; Rossi J; Alderete D; Alonso DF; Szijan I; Chantada GL
Br J Ophthalmol; 2018 Nov; 102(11):1597-1601. PubMed ID: 30150278
[TBL] [Abstract][Full Text] [Related]
6. Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
Dimaras H; Rushlow D; Halliday W; Doyle JJ; Babyn P; Abella EM; Williams J; Héon E; Gallie BL; Chan HS
Transl Res; 2010 Aug; 156(2):91-7. PubMed ID: 20627193
[TBL] [Abstract][Full Text] [Related]
7. A decision process for drug discovery in retinoblastoma.
Cancela MB; Zugbi S; Winter U; Martinez AL; Sampor C; Sgroi M; Francis JH; Garippa R; Abramson DH; Chantada G; Schaiquevich P
Invest New Drugs; 2021 Apr; 39(2):426-441. PubMed ID: 33200242
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma.
Ma H; Nie C; Chen Y; Li J; Xie Y; Tang Z; Gao Y; Ai S; Mao Y; Sun Q; Lu R
Oncol Res; 2021 Sep; 28(7):745-761. PubMed ID: 33573708
[TBL] [Abstract][Full Text] [Related]
9. Assessment of retinoblastoma RNA reflux after intravitreal injection of melphalan.
Winter U; Nicolas M; Sgroi M; Sampor C; Torbidoni A; Fandiño A; Chantada GL; Munier FL; Schaiquevich P
Br J Ophthalmol; 2018 Mar; 102(3):415-418. PubMed ID: 29089355
[TBL] [Abstract][Full Text] [Related]
10. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
[TBL] [Abstract][Full Text] [Related]
11. De novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma.
Schueler AO; Anastassiou G; Jurklies C; Havers W; Wieland R; Bornfeld N
Retina; 2006 Apr; 26(4):425-31. PubMed ID: 16603962
[TBL] [Abstract][Full Text] [Related]
12. Translational screening platform to evaluate chemotherapy in combination with focal therapy for retinoblastoma.
Sinenko IL; Kuttler F; Simeonov V; Moulin A; Aouad P; Stathopoulos C; Munier FL; Berger A; Dyson PJ
Cancer Sci; 2023 Sep; 114(9):3728-3739. PubMed ID: 37340597
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for retinoblastoma.
Chan HS; Gallie BL; Munier FL; Beck Popovic M
Ophthalmol Clin North Am; 2005 Mar; 18(1):55-63, viii. PubMed ID: 15763191
[TBL] [Abstract][Full Text] [Related]
14. Trilateral retinoblastoma with pituitary-hypothalamic dysfunction.
Dai S; Dimaras H; Héon E; Budning A; Doyle J; Halliday W; Drake J; Gallie BL; Chan HS
Ophthalmic Genet; 2008 Sep; 29(3):120-5. PubMed ID: 18766991
[TBL] [Abstract][Full Text] [Related]
15. Characterization of NCC-RbC-51, an RB cell line isolated from a metastatic site.
Ravishankar H; Mangani AS; Shankar MB; Joshi M; Devasena T; Parameswaran S; Subramaniam K
Histochem Cell Biol; 2020 Feb; 153(2):101-109. PubMed ID: 31781967
[TBL] [Abstract][Full Text] [Related]
16. Targeting the p53 pathway in retinoblastoma with subconjunctival Nutlin-3a.
Brennan RC; Federico S; Bradley C; Zhang J; Flores-Otero J; Wilson M; Stewart C; Zhu F; Guy K; Dyer MA
Cancer Res; 2011 Jun; 71(12):4205-13. PubMed ID: 21515735
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo.
Zhou Z; Jiang H; Xia J; Zhang J
Int J Oncol; 2020 Sep; 57(3):697-706. PubMed ID: 32582992
[TBL] [Abstract][Full Text] [Related]
18. Establishment and Characterization of Carboplatin-Resistant Retinoblastoma Cell Lines.
Cho CS; Jo DH; Kim JH; Kim JH
Mol Cells; 2022 Oct; 45(10):729-737. PubMed ID: 36047446
[TBL] [Abstract][Full Text] [Related]
19. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal HDAC Inhibitor Belinostat Effectively Eradicates Vitreous Seeds Without Retinal Toxicity In Vivo in a Rabbit Retinoblastoma Model.
Kaczmarek JV; Bogan CM; Pierce JM; Tao YK; Chen SC; Liu Q; Liu X; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Friedman DL; Richmond A; Daniels AB
Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):8. PubMed ID: 34757417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
